Adjuvant therapy in stage II colon cancer: Current approaches

被引:30
作者
Baddi, L [1 ]
Benson, A [1 ]
机构
[1] Northwestern Univ, Div Hematol Oncol, Chicago, IL 60611 USA
关键词
colon cancer; stage II; adjuvant chemotherapy;
D O I
10.1634/theoncologist.10-5-325
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:325 / 331
页数:7
相关论文
共 28 条
[1]   Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer [J].
Andre, T ;
Boni, C ;
Mounedji-Boudiaf, L ;
Navarro, M ;
Tabernero, J ;
Hickish, T ;
Topham, C ;
Zaninelli, M ;
Clingan, P ;
Bridgewater, J ;
Tabah-Fisch, I ;
de Gramont, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2343-2351
[2]  
[Anonymous], 2008, NATL COMPREHENSIVE C
[3]  
Baron JA, 2002, CANCER PRECURSORS: EPIDEMIOLOGY, DETECTION, AND PREVENTION, P127
[4]   American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer [J].
Benson, AB ;
Schrag, D ;
Somerfield, MR ;
Cohen, AM ;
Figueredo, AT ;
Flynn, PJ ;
Krzyzanowska, MK ;
Maroun, J ;
McAllister, P ;
Van Cutsem, E ;
Brouwers, M ;
Charette, M ;
Haller, DG .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) :3408-3419
[5]  
Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979
[6]  
Engstrom Paul F, 2003, J Natl Compr Canc Netw, V1, P40
[7]   Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer [J].
Erlichman, C ;
O'Connell, M ;
Kahn, M ;
Marsoni, S ;
Torri, V ;
Tardio, B ;
Zaniboni, A ;
Pancera, G ;
Martignoni, G ;
Labianca, R ;
Barni, A ;
Seitz, JF ;
Milan, C ;
Bedenne, L ;
Giovannini, M ;
Letreut, YP ;
Skillings, J ;
Shepard, L ;
Zee, B ;
Petrioli, R ;
Francini, G .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) :1356-1363
[8]   Adjuvant therapy for stage II colon cancer: A systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group [J].
Figueredo, A ;
Charette, ML ;
Maroun, J ;
Brouwers, MC ;
Zuraw, L .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) :3395-3407
[9]   Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer:: Who benefits and by how much? [J].
Gill, S ;
Loprinzi, CL ;
Sargent, DJ ;
Thomé, SD ;
Alberts, SR ;
Haller, DG ;
Benedetti, J ;
Francini, G ;
Shepherd, LE ;
Seitz, JF ;
Labianca, R ;
Chen, W ;
Cha, SS ;
Heldebrant, MP ;
Goldberg, RM .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (10) :1797-1806
[10]  
Gray RG, 2004, J CLIN ONCOL, V22, p245S